Search hospitals > California > Orange
UC Irvine Health/Chao Family Comprehensive Cancer Center
Claim this profileOrange, California 92868
Global Leader in Breast Cancer
Global Leader in Ovarian Cancer
Conducts research for Cancer
Conducts research for Lung Cancer
Conducts research for Pancreatic Cancer
519 reported clinical trials
47 medical researchers
Summary
UC Irvine Health/Chao Family Comprehensive Cancer Center is a medical facility located in Orange, California. This center is recognized for care of Breast Cancer, Ovarian Cancer, Cancer, Lung Cancer, Pancreatic Cancer and other specialties. UC Irvine Health/Chao Family Comprehensive Cancer Center is involved with conducting 519 clinical trials across 517 conditions. There are 47 research doctors associated with this hospital, such as David Hong, MD, Farshid Dayyani, Deepa Jeyakumar, and Ritesh Parajuli, MD.Area of expertise
1Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
2Ovarian Cancer
Global LeaderStage IV
Stage I
Stage III
Top PIs
David Hong, MDM D Anderson Cancer Center4 years of reported clinical research
Expert in Pancreatic Cancer
Expert in Solid Tumors
32 reported clinical trials
61 drugs studied
Farshid DayyaniUC Irvine Health/Chao Family Comprehensive Cancer Center2 years of reported clinical research
Studies Pancreatic Cancer
Studies Cancer
26 reported clinical trials
55 drugs studied
Deepa JeyakumarUC Irvine Health/Chao Family Comprehensive Cancer Center4 years of reported clinical research
Expert in Acute Myelogenous Leukemia
Expert in Acute Myeloid Leukemia
20 reported clinical trials
47 drugs studied
Ritesh Parajuli, MDUC Irvine Health/Chao Family Comprehensive Cancer Center2 years of reported clinical research
Expert in Breast Cancer
Expert in Breast cancer
19 reported clinical trials
46 drugs studied
Clinical Trials running at UC Irvine Health/Chao Family Comprehensive Cancer Center
Pancreatic Cancer
Breast Cancer
Cancer
Colorectal Cancer
Bladder Cancer
Breast cancer
Colon Cancer
Ovarian Cancer
Esophageal cancer
Kidney Cancer
Perioperative Chemotherapy
for Pancreatic Cancer
This phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer that can be removed by surgery (removable/resectable). Chemotherapy drugs, such as fluorouracil, irinotecan, leucovorin, and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy before and after surgery (perioperatively) may work better in treating patients with pancreatic cancer compared to giving chemotherapy after surgery (adjuvantly).
Recruiting4 awards Phase 318 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Radiation Therapy
for Cancer with Bone Metastasis
This phase III trial compares the effect of adding radiation therapy to usual care on the occurrence of bone-related complications in cancer patients with high-risk bone metastases that are not causing symptoms (asymptomatic). High-risk bone metastases are defined by their location (including hip, shoulder, long bones, and certain levels of the spine), or size (2 cm or larger). These bone metastases appear to be at higher risk of complications such as fracture, spinal cord compression, and/or pain warranting surgery or radiation treatment. Radiation therapy uses high energy x-rays to kill cancer cells and shrink tumors. The total dose of radiation can be delivered in a single day or divided in smaller doses for up to 5 days of total treatment. Usual care for asymptomatic bone metastases may include drugs that prevent bone loss, in addition to the treatment for the primary cancer or observation (which means no treatment until symptoms appear). Evidence has shown that preventative radiation therapy may be effective in lowering the number of bone metastases-related complications, however, it is not known if this approach is superior to usual care. Adding radiation therapy to usual care may be more effective in preventing bone-related complications than usual care alone in cancer patients with asymptomatic high-risk bone metastases.
Recruiting2 awards Phase 37 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at UC Irvine Health/Chao Family Comprehensive Cancer Center?
UC Irvine Health/Chao Family Comprehensive Cancer Center is a medical facility located in Orange, California. This center is recognized for care of Breast Cancer, Ovarian Cancer, Cancer, Lung Cancer, Pancreatic Cancer and other specialties. UC Irvine Health/Chao Family Comprehensive Cancer Center is involved with conducting 519 clinical trials across 517 conditions. There are 47 research doctors associated with this hospital, such as David Hong, MD, Farshid Dayyani, Deepa Jeyakumar, and Ritesh Parajuli, MD.
Where is UC Irvine Health/Chao Family Comprehensive Cancer Center located?
**UC Irvine Health/Chao Family Comprehensive Cancer Center**
- **Address:** 101 The City Drive South, Building 23, Orange, CA 92868.
- **Location:** Situated in the city of Orange, California, and easily accessible via the I-5 freeway.
Who should I call to ask about financial aid or insurance network?
**UC Irvine Health/Chao Family Comprehensive Cancer Center Contact Information:**
- **Financial Assistance:**
- Website: [Financial Assistance Information](https://www.ucihealth.org/patients-visitors/financial-assistance)
- Phone: 833-353-7700 (Monday-Friday, 8:30 a.m. - 4 p.m.)
- **Insurance Inquiries:**
- Website: [Insurance Information](https://www.ucihealth.org/patients-visitors/insurance)
- For specific questions, contact the physician group listed on the insurance page.
- **General Information:**
- Main Website: [UCI Chao Family Comprehensive Cancer Center](https://cancer.uci.edu)
What insurance does UC Irvine Health/Chao Family Comprehensive Cancer Center accept?
UC Irvine Health/Chao Family Comprehensive Cancer Center accepts a wide range of insurance plans. This includes PPOs such as Aetna, Anthem Blue Cross, and United Healthcare; HMOs including Anthem Blue Cross, Blue Shield, and United Healthcare HMO; and Behavioral Health plans like Anthem Behavioral Health and Optum Behavioral Health. They also accept Covered California plans, Medicare, and Medi-Cal.
What awards or recognition has UC Irvine Health/Chao Family Comprehensive Cancer Center received?
The UC Irvine Health/Chao Family Comprehensive Cancer Center, located in Orange, California, is recognized as a top cancer center by the National Cancer Institute (NCI), holding the prestigious "comprehensive" designation. It is one of only 53 NCI-designated comprehensive cancer centers in the U.S. and the sole center in Orange County. The center excels in scientific discovery, clinical innovation, and efforts to reduce cancer incidence and mortality, especially in underserved communities.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.